Heffernan Mark

CIK 00016324391 companyBLACKROCK, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001632439

Recent Transactions

28 trades

Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−243,587→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Restricted Share Units
2017-07-31$6.59/sh−106,929→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Option to Purchase Ordinary Shares
2017-07-31$6.59/sh−9,203→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Option to Purchase Ordinary Shares
2017-07-31−100,000→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Restricted Share Units
2017-07-31$6.59/sh−50,000→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−109,810→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Option to Purchase Ordinary Shares
2017-07-31$6.59/sh−4,833→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Option to Purchase Ordinary Shares
2017-07-31$0.37/sh−52,040→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+35,643→ 109,810 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+25,000→ 74,167 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-07-01−35,643→ 106,929 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-07-01−25,000→ 50,000 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-09-05+142,572→ 142,572 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2016-07-01$0.13/sh+25,000→ 49,167 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2016-07-01$0.13/sh+4,833→ 24,167 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-07-01−25,000→ 75,000 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2016-07-01−4,833→ 4,833 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2015-11-23−7,250→ 9,666 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-11-23$0.13/sh+7,250→ 19,334 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2015-11-20−9,204→ 9,203 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-11-20$0.13/sh+9,204→ 243,587 total
Award
Nexvet Biopharma plc
Restricted Share Units
2015-09-03+100,000→ 100,000 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2015-08-20−4,834→ 16,916 total
Award
Nexvet Biopharma plc
Ordinary Shares
2015-08-20$0.13/sh+4,834→ 12,084 total
Award
Nexvet Biopharma plc
Ordinary Shares
2015-06-08$0.13/sh+7,250→ 7,250 total
Award
Nexvet Biopharma plc
Option to Purchase Shares
2015-05-18+100,000→ 100,000 total
Conversion
Nexvet Biopharma plc
Series A Investment Preference Shares
2015-02-10−4,424→ 0 total
Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-02-10+4,424→ 234,383 total

Companies

Nexvet Biopharma plc
Chief Executive Officer

Recent Filings

Address

C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE, MOUNT MERRION

BLACKROCK, L2

View on SEC.gov